Business News


BiogenIdec-042314-lg.jpg Biotechnology company Biogen Idec, Inc. Wednesday reported 12 percent increase in the first-quarter profit, reflecting 51 percent growth in revenues, driven mainly by strong sales of multiple sclerosis or MS drug Tecfidera. Adjusted earnings missed analysts' estimates, while sales topped view. Further, the company lifted its fiscal 2014 forecast.
More

Baxter Says FDA OKs ADVATE With BAXJECT III Reconstitution System - Quick Facts



Baxter International Inc. (BAX) said the U.S. Food and Drug Administration or FDA has approved a new reconstitution system for Antihemophilic Factor [Recombinant] or ADVATE. ADVATE and the diluent come pre-packaged in the new BAXJECT III reconstitution system. "ADVATE has the widest range of dosage...
More

Latest News
More

Everest Re Group Profit Falls, Yet Tops Street - Quick Facts


Insurance company Everest Re Group Ltd (RE) Wednesday reported first-quarter net earnings of $293.9 million or $6.21 per share, compared with $384 million or $7.50 per share last year. Excluding items, operating earnings for the quarter were $281 million or $5.93 per share, compared with $301 million...
More
newhomesales-042314.jpg

U.S. New Home Sales Unexpectedly Show Steep Drop In March


New home sales in the U.S. unexpectedly showed a substantial decrease in the month of March, according to a report released by the Commerce Department on Wednesday, with sales falling to their lowest level in eight months. The report said new home sales plunged 14.5 percent to an annual rate of 384,000 in March from the revised February rate of 449,000.

U.S. New Home Sales Tumble 14.5% In March

More

Body Central Announces Review Of Strategic Options


Banc Of California To Acquire Popular Community Bank’s California Branch Network

More

FMC Technologies Inc. (FTI) Is Challenging The Highs After Q1 Report


FMC Technologies Inc. (FTI) reported first quarter EPS of $0.57 after the close Tuesday, compared to $0.43 a year ago. Analysts expected EPS of $0.50. Full year 2014 EPS is expected to be between $2.55 and $2.75. The consensus estimate is for EPS of $2.65. FMC Technologies gapped open sharply higher...
More

MCig's Subsidiary VitaCig Files For IPO - Quick Facts


mCig Inc. (MCIG.OB) announced that its wholly owned subsidiary VitaCig Inc. has filed a Form S-1 with the Securities and Exchange Commission or SEC for the registration of 250 million VitaCig shares that will be paid out to mCig shareholders as a dividend on the record date. The record date has now been...
More

Agenus Annual Shareholder Meeting ; Webcast At 5:00 PM ET


Agenus Inc.(AGEN) Annual Shareholder Meeting in Forbes Road, Lexington, MA 02421. The event is scheduled to begin at 5:00 PM ET April 23, 2014. To access the live webcast, log on at www.agenusbio.com/webcast/
More